Table 1. Characteristics of study participants, by HCV genotype group.
| HCV genotype | All | 1a | 1b | 2a | 2b | 3a | 4a | Others |
|---|---|---|---|---|---|---|---|---|
| N | 8729 | 3548 (41) | 1924 (22) | 304 (3) | 472 (5) | 1839 (21) | 193 (2) | 449 (5) |
| Europeans Asians Africans Others |
6704 (77) 1103 (13) 723 (8) 199 (2) |
2987 (84) 59 (2) 421 (12) 81 (2) |
1133 (59) 577 (30) 192 (10) 22 (1) |
100 (33) 197 (65) 7 (2) 0 (0) |
421 (89) 15 (3) 25 (5) 11 (2) |
1635 (89) 111 (6) 19 (1) 74 (4) |
178 (92) 2 (1) 8 (4) 5 (3) |
250 (56) 142 (32) 51 (11) 6 (1) |
| Cirrhosis | 2410 (28) | 978 (28) | 536 (28) | 35 (12) | 77 (16) | 629 (34) | 60 (31) | 95 (21) |
| Male sex | 5605 (64) | 2434 (69) | 1096 (57) | 141 (46) | 301 (64) | 1230 (67) | 143 (74) | 260 (58) |
| SVR | 7702 (88) | 3240 (91) | 1773 (92) | 273 (90) | 426 (90) | 1452 (79) | 153 (79) | 385 (86) |
Data are indicated as number (percent); SVR: sustained virological response after treatment.